MOLN: Bathi saben saham sajrone rolas wulan pungkasan Molecular Partners Ltd

Risks for Molecular Partners AG (MOLN) are linked to the creation of innovative darpin proteins to combat viruses and cancer. This daily price chart of the annual EPS TTM on GURU.Markets helps assess stability, where the -1.69 mark characterizes this parameter. Business resilience is supported by alliances with pharma behemoths for the development of biologics and high demand for ophthalmology platforms, which expands the contract network.

MOLN Bathi saben saham sajrone rolas wulan pungkasan molecularpartners.com (04.07.2022 - 14.11.2026)

molecularpartners.com (MOLN) - rincian metrik lan laporan keuangan

- rega saham lan prakiraan rega para ahli:

Kutipan saham Molecular Partners AG|MOLN - Konsensus nilai wajar

- informasi kapitalisasi pasar:

Nilai pasar Molecular Partners AG|MOLN - Nilai Wutuh Bisnis

- data nilai buku modal saham:

Aset Bersih saben Siji Saham Molecular Partners|MOLN - Nilai Buku Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku molecularpartners.com|MOLN - Total Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Rasio Total Utang marang Ekuitas Molecular Partners AG|MOLN - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang modal Molecular Partners|MOLN - Gunggung tanggungan utang perusahaan|Rasio utang marang kapitalisasi buku Molecular Partners AG|MOLN - Utang jangka dawa|Utang jangka cendhak perusahaan Molecular Partners|Likuiditas cepet molecularpartners.com

- data bathi lan kelipatan valuasi:

MOLN - Penghasilan resik|Bathi sing dikarepake Molecular Partners AG|MOLN - Periode bali modal bisnis|Rega marang bathi mangsa ngarep Molecular Partners AG|MOLN - Pangali rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Molecular Partners AG|MOLN - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Molecular Partners|MOLN - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan molecularpartners.com|MOLN - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Molecular Partners AG

- indikator dodolan lan pendapatan:

MOLN - Dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan Molecular Partners|MOLN - Multiplikator P/S|Rasio rega marang prakiraan pendapatan Molecular Partners AG

Ringkesan analisis perusahaan:MOLN - Molecular Partners AG

The specifics of Molecular Partners AG (MOLN), featuring its DARPin platform and cost-sharing arrangements with pharma behemoths, directly impact the business's bottom-line profitability. This metric is calculated as the ratio of net income to the total number of shares, reflecting the actual earnings per share and allowing the annual net income per share trend to provide timely identification of the asset's fundamental value degradation or growth.

Pesaing utama

GERN: Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajroning taun lumaku NBTX (nanobiotix.com)|Bicycle Therapeutics plc (BCYC) - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben siji saham sajrone 12 wulan pungkasan CTMX (CytomX Pharma)|Bathi saben saham sajrone rolas wulan pungkasan Perspective Tx|Bathi saben saham sajrone rolas wulan pungkasan GNLX|Bathi resik saben saham (EPS TTM) ONCY|Bathi resik saben saham (EPS TTM) lisata.com (LSTA)|Moleculin Biotech - Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajrone patang kuartal pungkasan GRTX (Galera Therapeutics Inc.)|Molecular Templates Corp - Bathi resik saben saham (EPS TTM)